CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Bipolar disorder - Management
What adverse effects of maternal drug treatment should I be aware of in the neonate?
- Babies whose mothers have taken psychotropic drugs during pregnancy should be monitored in the first few weeks for adverse drug effects, drug toxicity, or withdrawal. Symptoms in the baby to be aware of include:
- Floppy baby syndrome.
- Irritability.
- Constant crying.
- Shivering, tremor.
- Restlessness.
- Increased tone.
- Feeding and sleeping difficulties.
- Seizures (rarely).
- If any of these occur, seek specialist paediatric advice.
Basis for recommendation
This recommendation is based on two published guidelines from the National Institute for Health and Clinical Excellence (NICE), Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, primary care and secondary care [National Collaborating Centre for Mental Health, 2006], and Antenatal and postnatal mental health [National Collaborating Centre for Mental Health, 2007].
© NHS Institute for Innovation and Improvement